Muscular Dystrophy, Duchenne
"Muscular Dystrophy, Duchenne" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
MeSH Number(s)
C05.651.534.500.300
C10.668.491.175.500.300
C16.320.322.562
C16.320.577.300
Concept/Terms
Muscular Dystrophy, Duchenne- Muscular Dystrophy, Duchenne
- Childhood Pseudohypertrophic Muscular Dystrophy
- Duchenne Muscular Dystrophy
- Dystrophy, Duchenne Muscular
- Duchenne-Type Progressive Muscular Dystrophy
- Duchenne Type Progressive Muscular Dystrophy
- Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type
- Muscular Dystrophy, Pseudohypertrophic
- Dystrophies, Pseudohypertrophic Muscular
- Dystrophy, Pseudohypertrophic Muscular
- Muscular Dystrophies, Pseudohypertrophic
- Pseudohypertrophic Muscular Dystrophies
- Pseudohypertrophic Muscular Dystrophy
- Muscular Dystrophy, Pseudohypertrophic, Childhood
- Progressive Muscular Dystrophy, Duchenne Type
- Pseudohypertrophic Childhood Muscular Dystrophy
- Pseudohypertrophic Muscular Dystrophy, Childhood
- Childhood Muscular Dystrophy, Pseudohypertrophic
- Muscular Dystrophy, Childhood, Pseudohypertrophic
Below are MeSH descriptors whose meaning is more general than "Muscular Dystrophy, Duchenne".
- Diseases [C]
- Musculoskeletal Diseases [C05]
- Muscular Diseases [C05.651]
- Muscular Disorders, Atrophic [C05.651.534]
- Muscular Dystrophies [C05.651.534.500]
- Muscular Dystrophy, Duchenne [C05.651.534.500.300]
- Nervous System Diseases [C10]
- Neuromuscular Diseases [C10.668]
- Muscular Diseases [C10.668.491]
- Muscular Disorders, Atrophic [C10.668.491.175]
- Muscular Dystrophies [C10.668.491.175.500]
- Muscular Dystrophy, Duchenne [C10.668.491.175.500.300]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Genetic Diseases, X-Linked [C16.320.322]
- Muscular Dystrophy, Duchenne [C16.320.322.562]
- Muscular Dystrophies [C16.320.577]
- Muscular Dystrophy, Duchenne [C16.320.577.300]
Below are MeSH descriptors whose meaning is more specific than "Muscular Dystrophy, Duchenne".
This graph shows the total number of publications written about "Muscular Dystrophy, Duchenne" by people in Harvard Catalyst Profiles by year, and whether "Muscular Dystrophy, Duchenne" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
2002 | 3 | 2 | 5 |
2003 | 1 | 0 | 1 |
2004 | 0 | 3 | 3 |
2005 | 5 | 0 | 5 |
2006 | 4 | 0 | 4 |
2007 | 6 | 0 | 6 |
2008 | 2 | 1 | 3 |
2009 | 3 | 2 | 5 |
2010 | 5 | 0 | 5 |
2011 | 4 | 1 | 5 |
2012 | 1 | 1 | 2 |
2013 | 7 | 2 | 9 |
2014 | 9 | 2 | 11 |
2015 | 7 | 1 | 8 |
2016 | 7 | 1 | 8 |
2017 | 8 | 1 | 9 |
2018 | 10 | 1 | 11 |
2019 | 10 | 2 | 12 |
2020 | 13 | 1 | 14 |
2021 | 7 | 2 | 9 |
2022 | 10 | 0 | 10 |
2023 | 5 | 0 | 5 |
2024 | 2 | 0 | 2 |
Below are the most recent publications written about "Muscular Dystrophy, Duchenne" by people in Profiles.
-
Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care. JAMA Netw Open. 2024 Jan 02; 7(1):e2353094.
-
The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report. J Neuromuscul Dis. 2024; 11(2):525-533.
-
DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism. FASEB J. 2023 10; 37(10):e23198.
-
Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy. N Engl J Med. 2023 Sep 28; 389(13):1203-1210.
-
Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy. Clin Biochem. 2023 Aug; 118:110614.
-
Newborn screening for Duchenne muscular dystrophy: A two-year pilot study. Ann Clin Transl Neurol. 2023 08; 10(8):1383-1396.
-
Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up. Stem Cell Rev Rep. 2023 07; 19(5):1340-1359.
-
Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy. Am J Med Genet C Semin Med Genet. 2022 Jun; 190(2):197-205.
-
Tandem duplication within the DMD gene in Labrador retrievers with a mild clinical phenotype. Neuromuscul Disord. 2022 10; 32(10):836-841.
-
Comparison of Quantitative Ultrasound Methods to Classify Dystrophic and Obese Models of Skeletal Muscle. Ultrasound Med Biol. 2022 09; 48(9):1918-1932.